Curis Lifesciences Limited Share Price & Stock Analysis

Curis Lifesciences Limited (NSE: CURIS) is a Sanand, Gujarat-based company in the Pharmaceutical Contract Manufacturing Services industry. With a market capitalisation of ₹138 Cr, it ranks #2,970 by market cap among the 6,197 Indian listed companies on FinBizNet, and #14 of 26 in Pharmaceutical Contract Manufacturing Services.

Key Metrics

Market Cap₹138 Cr
NSE SymbolCURIS
SectorHealth Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals
Sub-IndustryPharmaceuticals > Pharmaceutical Contract Manufacturing Services
Return on Equity14.61%
Return on Assets10.51%
52-Week Range₹177.10 – ₹181.00
HeadquartersSanand, Gujarat
Websitecurisls.com

Shareholding and Delivery

Promoters held 68.03% of Curis Lifesciences Limited's shares as of Mar 2026, unchanged from Nov 2025.

About Curis Lifesciences Limited

Curis Lifesciences Limited operates as a pharmaceutical manufacturer, specializing in manufacturing of a wide range of pharmaceutical products, such as tablets, capsules, external preparations, oral liquid, and sterile ophthalmic ointments in India. The company's business model operates through loan license manufacturing, through which, the company carry outs manufacturing under Loan License arrangement for domestic suppliers, where all raw materials and excipients are procured and delivered by the client; contract manufacturing, where the company carry outs manufacturing under Contract Manufacturing arrangement for merchant exporters and domestic suppliers, where it would be responsible for procuring and handling all ingredients, raw materials, and packaging materials; and Direct Export/Own Brand Manufacturing, under which the company manufactures products registered by itself in foreign country and sells the said products in foreign country through its distribution. Curis Lifescience

Products and Services

1. Drug Delivery Systems-This segment provides contract manufacturing services for pharmaceutical formulations and products. 2. NA-NA 3. NA-NA 4. NA-NA

Business Segments

1. Drug Delivery Systems-100%

Curis Lifesciences Limited vs Peers — Pharmaceutical Contract Manufacturing Services

CompanyMarket CapP/EROELatest Qtr Revenue1Y Change
Torrent Pharma Ltd.₹1,79,494 Cr73.616.98%₹4,979 Cr+30.4%
Aether Industries Limited₹21,710 Cr101.89.81%₹347 Cr+127.8%
Alivus Life Sciences Ltd₹17,862 Cr31.518.36%₹682 Cr+64.0%
Aarti Pharmalabs Ltd₹8,374 Cr52.58.49%₹610 Cr+15.4%
Solara Active Pharma Sciences Limited₹3,225 Crn/m-0.63%₹417 Cr+22.1%
Sai Parenteral's Limited₹2,235 Cr115.82.88%₹195 Cr—
KRM Ayurveda Limited₹521 Cr25.917.54%₹32 Cr—
Trident Lifeline Limited₹511 Cr26——+37.6%
Curis Lifesciences Limited₹138 Cr—14.61%——

Listed by market capitalisation. Ratios are shown for context only.

Frequently Asked Questions

Which sector does Curis Lifesciences Limited belong to?

Curis Lifesciences Limited operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Pharmaceuticals space (Pharmaceuticals > Pharmaceutical Contract Manufacturing Services).

What are the key financial ratios of Curis Lifesciences Limited?

Curis Lifesciences Limited has a return on equity of 14.61%.

What is the stock symbol of Curis Lifesciences Limited?

Curis Lifesciences Limited is listed on the NSE under the symbol CURIS.

What is the promoter holding in Curis Lifesciences Limited?

Promoters held 68.03% of Curis Lifesciences Limited's shares as of Mar 2026, unchanged from Nov 2025.

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.